What is this website for? This website was created to promote a series of articles on research published in early 2014 in the leading medical journal The Lancet. The website is a platform to share and exchange documentation, information, and resources to help increase the value of research and reduce waste in research.
It has been estimated that 85% of research is wasted, usually because it asks the wrong questions, is badly designed, not published or poorly reported. While this primarily diminishes the value of research, it also represents a significant financial loss: an estimated US$ 240,000,000,000 were wasted in Life Sciences research in 2010. However, many causes of this waste are simple problems that could easily be fixed.
THE LANCET SERIES: The five papers in the series report on the most pressing issues, recommend how to increase value and reduce waste in biomedical research, and propose metrics for stakeholders to monitor the implementation of these recommendations. Besides providing direct links to the articles, this website also hosts speaker presentations from the symposium on the article series held in January 2014.
REWARD WORKING GROUPS: Several working groups have formed in response to the issues in the series: funders, editors, research institutions, and regulation and governance. For description and contact details of these, please see REWARD Working Groups.
NEWS AND BLOGS: A news and blog section and an event calendar keep you up-to-date with the latest developments on relevant topics and a resource section provides links to other websites and tools that aim to increase the value of research.
THE REWARD PRIZE: To stimulate and promote research in this area, Cochrane has created the Cochrane-REWARD prize.
This information will hopefully help to answer the right questions in research, address uncertainty in clinical practice and ultimately improve patient outcomes.
"Progress has been made towards reducing the 85% of wasted effort in medical research—and the huge amounts of money misspent and harm caused to patients—but there’s still a long way to go"
- Paul Glasziou, Iain Chalmers